A Patient Is Waiting
When you need confidence that your critical therapies are being transported safely in contaminant-free equipment, Trust Cryoport. Our new Advanced Therapy Shipper™ (ATS) product line, a first-of-its-kind fleet, contains shippers dedicated exclusively to cell and gene supply chain management for both clinical and commercial therapies.
Your patients are waiting, so we provide unmatched traceability of your shipments — giving you confidence that your samples will arrive intact and in line with even the newest regulatory guidance. Additionally, Cryoport’s Advanced Therapy Shipper™ fleet was specifically designed to meet the newly released ISO 21973 standard − General requirements for transportation of cells for therapeutic use. We guarantee your shipper has never contained non-human-based materials, virtually eliminating any possibility of cross-contamination.
We created our new fleet to meet strong market demand and anticipated government regulations requiring stricter safeguards on the transportation of patients’ critical therapies. That’s why, as part of our Chain of Compliance® solution, our ATS shippers integrate into our Cryoportal® Logistics Management Platform, which offers complete transparency of all equipment, components, and commodities, including historical use, performance, handling, cleaning, and disinfection of the equipment.
A first-of-its-kind fleet dedicated exclusively to both clinical and commercial advanced therapy supply chain management
The only materials our brand new, shipping fleet safeguards and transports to patients in need
Specific methods and instructions that ensure all shipper components and materials maintain defined standards to ensure protection from cross-contamination
Logic implemented via the Cryoportal® Logistics Management Platform that ensures blue shippers are used exclusively for human advanced therapies
A specialized set of logistic operations that ensures ATS shippers are free of cross-contamination by handling them separately from other fleets
A series of procedures that each ATS shipper goes through — including physical suitability, cleanliness, LN2 capacity, and minimum required hold times — before being shipped to its next destination
A guarantee that each shipper is dedicated to advanced cell and gene therapy supply chain management and is certified as human use only throughout its life
Cleaning and disinfection procedures that virtually eliminate the potential risk of cross-contamination of materials and reduce external contaminates by 99.9999%. Learn more
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC